CAR-T-Therapie Marktgröße, Anteilsanalyse bis 2025-2031
CAR-T Therapy Market Report Analysis
CAR-T Therapy Market
-
CAGR (2025 - 2031)16.2% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Novartis International AG
- Kite Pharma, Inc. (Gilead Sciences, Inc.)
- Juno Therapeutics (Celgene Corporation)
- Bluebird Bio, Inc. (Celgene Corporation)
- Sorrento Therapeutics Inc.
- Mustang Bio, Inc
- Aurora Biopharma Inc.
- Legend Biotech (Genscript Biotech Corporation)
- Pfizer, Inc.
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation
By Zielantigen
- CD 19
- BCMA
- HER2
- GD2
- CD 20
- CD22
- CD30
- CD33
- HER1 und andere
By Therapeutische Anwendung
- Akute Lymphatische Leukämie
- Chronische Lymphatische Leukämie
- Diffuses Großzelliges B-Zell-Lymphom
- Follikuläres Lymphom
- Multiples Myelom
- Glioblastom
- Sarkom
- Neuroblastom
- Akute Myeloische Leukämie
- Brustkrebs
- Bauchspeicheldrüsenkrebs
- Leberzellkarzinom
- Dickdarmkrebs und andere
By Geographie
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Get Free Sample For